Renew Group

Renew Group is a global healthcare and wellness company specializing in non-invasive medical technologies, particularly External Counterpulsation (ECP) therapy. The company's flagship product, the Renew NCP-5, is a sophisticated medical device designed to enhance blood circulation and improve cardiovascular health by synchronizing with the patient's cardiac cycle. This therapy is primarily indicated for chronic conditions such as refractory angina and heart failure, offering a non-surgical alternative for patients who have exhausted traditional treatment options. In addition to its clinical applications, Renew Group markets its technology for sports recovery and general wellness, aiming to optimize circulatory efficiency and physical performance. Headquartered in Singapore, the company maintains a global presence and continues to expand its portfolio of health-optimizing solutions.